iiinova — where your digital self keeps evolving

Nature Biotechnology @natbiotech.nature.com · 5h

Behind (cell) walls www.nature.com/articles/s41...

Nature Biotechnology @natbiotech.nature.com · 15/09/2026

A new class of biotech buyer is emerging, as frontier AI and big tech companies acquire early-stage biology foundational platforms. What are the potential implications for founders, investors and the pharmaceutical industry? www.nature.com/articles/s41... rdcu.be/URMEtSZqA84a

020

Nature Biotechnology @natbiotech.nature.com · 11/09/2026

From reading to writing DNA writing is entering a period of rapid innovation, with enzymatic and cellular approaches challenging decades-old chemistry www.nature.com/articles/s41...

094

Nature Biotechnology @natbiotech.nature.com · 11/09/2026

The September issue is live www.nature.com/nbt/volumes/... On the cover, Bushin et al. present a growth-coupling system in which bacteria survive only if they make both a key metabolite and xanthommatin, an animal pigment difficult to obtain at scale go.nature.com/3Ll0VeT rdcu.be/yK755byv7zca

162

Nature Biotechnology @natbiotech.nature.com · 09/09/2026

An analysis of FDA-approved drugs reveals uneven timing and concentration of revenue life cycles across modalities and therapeutic areas, offering evidence to guide innovation strategy and policy design in a post-Inflation Reduction Act world www.nature.com/articles/s41... rdcu.be/uimZBPj6Pr3a

031

Nature Biotechnology @natbiotech.nature.com · 01/09/2026

DNA writing is entering a period of rapid innovation, with enzymatic and cellular approaches challenging decades-old chemistry. Continued advances promise to remove one of the field’s most persistent bottlenecks and enable experiments that are currently out of reach www.nature.com/articles/s41...

061

Nature Biotechnology @natbiotech.nature.com · 27/08/2026

Developing a genetic toolkit for manipulating abundant intestinal microbes #NBTintheNews via @weillcornell.bsky.social news.weill.cornell.edu/news/2026/08...

140

Nature Biotechnology @natbiotech.nature.com · 20/08/2026

From reading to writing www.nature.com/articles/s41...

020

Nature Biotechnology @natbiotech.nature.com · 19/08/2026

Lessons from drug revenue life cycles: distributions across modalities and therapeutic areas - @harvardkennedy.bsky.social www.nature.com/articles/s41...

120

Nature Biotechnology @natbiotech.nature.com · 18/08/2026

Join Nature Conferences at Princeton University this October to hear the latest electron microscopy instrumentation and methods driving progress in the physical and life sciences. Abstract submission deadline extended til August 21! go.nature.com/4h0zAME

131

Nature Biotechnology @natbiotech.nature.com · 14/08/2026

031

Nature Biotechnology @natbiotech.nature.com · 13/08/2026

The invisible tax of US visa bureaucracy on international scholars - @mayankchugh.bsky.social www.nature.com/articles/s41...

021

Nature Biotechnology @natbiotech.nature.com · 11/08/2026

The August issue is live nature.com/nbt/volumes/... On the cover, Azadian et al. develop a focused ultrasound protocol that clears pathogenic debris from the brain through the meningeal lymphatics in two mouse models of stroke go.nature.com/4nO5s71 rdcu.be/fzlEz

092

Nature Biotechnology @natbiotech.nature.com · 05/08/2026

Biotech’s digital twin dilemma www.nature.com/articles/s41... rdcu.be/fx5Fm

061

Nature Biotechnology @natbiotech.nature.com · 04/08/2026

Hybrid quantum–classical computer systems act as a bridge to achieving quantum advantage, but they are not likely to scale well to the number of qubits required for use cases that are projected to eventually benefit most from quantum computing www.nature.com/articles/s41...

000

Nature Biotechnology @natbiotech.nature.com · 04/08/2026

As biotech evolves to shape economic strength, national resilience and geopolitical influence, the industry must commit to rebuilding and preserving public trust in the face of growing pressures on the institutions that underpin scientific leadership www.nature.com/articles/s41... rdcu.be/fxOKG

030

Nature Biotechnology @natbiotech.nature.com · 30/07/2026

Ten commitments for a bold biotechnology industry - @jeremymax.bsky.social www.nature.com/articles/s41...

093

Nature Biotechnology @natbiotech.nature.com · 29/07/2026

Diverse stakeholders were surveyed to characterize three key factors influencing healthcare innovation, including the role of institutional players, projected areas of development and persistent barriers to implementation www.nature.com/articles/s41... rdcu.be/fwI8K

040

Nature Biotechnology @natbiotech.nature.com · 24/07/2026

KAUST researchers develop new method for more precise plant engineering #NBTintheNews www.kaust.edu.sa/en/news/kaus...

141

Nature Biotechnology @natbiotech.nature.com · 22/07/2026

Imaging offers clearer insights to cancer #NBTintheNews via @glasgow.ac.uk www.gla.ac.uk/news/headlin...

010

Nature Biotechnology @natbiotech.nature.com · 21/07/2026

ENVnet provides a global molecular resource of dissolved organic matter - @berkeleylab.lbl.gov @jgi.doe.gov www.nature.com/articles/s41...

031

Nature Biotechnology @natbiotech.nature.com · 17/07/2026

The SynCell Asia Initiative outlines a strategy for developing core functional modules followed by their systems-level integration through the establishment of a centralized, AI-driven biofoundry go.nature.com/4tW9FZg rdcu.be/fugoc

000

Nature Biotechnology @natbiotech.nature.com · 14/07/2026

Quantum computing in transition Hybrid quantum–classical computers will achieve quantum advantage in biotechnology, bridging the time until a full quantum computer becomes available www.nature.com/articles/s41...

0110

Nature Biotechnology @natbiotech.nature.com · 14/07/2026

The July issue is live nature.com/nbt/volumes/... On the cover, @ycongzhang.bsky.social @efranzosa.bsky.social @hutlab.bsky.social introduce FUGAsseM, a method that uses microbial community data to infer the functions of previously uncharacterized gene products go.nature.com/435C4lp rdcu.be/ftNUV

0153

Nature Biotechnology @natbiotech.nature.com · 07/07/2026

Frontier AI companies as biotech acquirers www.nature.com/articles/s41...

1128

Nature Biotechnology @natbiotech.nature.com · 06/07/2026

Quantum computing in transition www.nature.com/articles/s41...

061

Nature Biotechnology @natbiotech.nature.com · 26/06/2026

For years, the idea of targeted protein degradation stalled because PROTACs were too large and unstable for clinical use. However, in the beginning of May, @fda.gov approved the use of the first PROTAC for adults with a certain form of metastatic breast cancer go.nature.com/4x3NYt7

091

Nature Biotechnology @natbiotech.nature.com · 17/06/2026

Educating for translation www.nature.com/articles/s41...

020

Nature Biotechnology @natbiotech.nature.com · 16/06/2026

Marked for destruction The significance of the first FDA-approved PROTAC lies not in proving that targeted protein degradation is superior to conventional therapies, but in proving that degrading proteins is possible as a therapeutic go.nature.com/4x3NYt7

032

Nature Biotechnology @natbiotech.nature.com · 16/06/2026

The June issue is live www.nature.com/nbt/volumes/... On the cover, Liu et al. present a solid tumor system that supports CAR‑T delivery and real‑time analysis of tumor–CAR‑T dynamics, evaluation of engineering strategies, and identification of druggable targets go.nature.com/3Jc62gv rdcu.be/foISS

021

Nature Biotechnology @natbiotech.nature.com · 10/06/2026

RNA at the Bench and Bedside is back for a 5th time, covering all the latest advances in nucleic acid medicines, from clinical trials to AI methods. Organized in partnership with Ionis Pharma, Alnylam & UCSD School of Medicine. Register now! go.nature.com/4xgXqJZ

042

Nature Biotechnology @natbiotech.nature.com · 04/06/2026

Marked for destruction go.nature.com/4x3NYt7

021

Nature Biotechnology @natbiotech.nature.com · 03/06/2026

Circling back to RNA vaccines While circRNA is often framed as a more stable, longer-lasting alternative to linear mRNA, its real-world advantages remain largely theoretical, and it is unclear whether greater molecular stability will translate into meaningful clinical gains go.nature.com/3RzqxHN

042

Nature Biotechnology @natbiotech.nature.com · 02/06/2026

Wearable ultrasound patch could help doctors spot danger signs in pregnancy earlier #NBTintheNews via @ox.ac.uk www.ox.ac.uk/news/2026-05...

130

Nature Biotechnology @natbiotech.nature.com · 01/06/2026

Asia unveils 10-year roadmap for artificial life research #NBTintheNews qazinform.com/news/asia-un...

110

Nature Biotechnology @natbiotech.nature.com · 26/05/2026

Research spotlight: Researchers develop mRNA strategy to turn “cold” tumors “hot” #NBTintheNews via @mgbresearch.bsky.social www.massgeneralbrigham.org/en/about/new...

042

Nature Biotechnology @natbiotech.nature.com · 26/05/2026

A framework for building a synthetic cell from the SynCell Asia Initiative go.nature.com/4tW9FZg

190

Nature Biotechnology @natbiotech.nature.com · 18/05/2026

While circRNA is often framed as a more stable, longer-lasting alternative to linear mRNA, its real-world advantages remain largely theoretical, and it is unclear whether greater molecular stability will translate into meaningful clinical gains go.nature.com/3RzqxHN

050

Nature Biotechnology @natbiotech.nature.com · 18/05/2026

The May issue is live nature.com/nbt/volumes/... On the cover, Zhang et al. describe an antibody-based therapy against drug-resistant S. aureus. The antibody conjugate selectively binds to the wall teichoic acid of the bacteria and enriches calcium on the cell envelope go.nature.com/3UaGItg

1186

Nature Biotechnology @natbiotech.nature.com · 13/05/2026

As measurement resolution, depth and throughput improve in single-cell and spatial proteomics, progress is increasingly constrained not by experimental sensitivity but by the ability to integrate proteomic data across experiments, modalities and spatial contexts go.nature.com/3NHDkGP rdcu.be/fij7N

041

Nature Biotechnology @natbiotech.nature.com · 12/05/2026

The US Supreme Court’s decision in Loper Bright, along with federal spending cuts, may limit the potential of synthetic biology to provide innovative solutions for environmental challenges, medicine and biomanufacturing go.nature.com/4cE794D rdcu.be/fikex

031

Nature Biotechnology @natbiotech.nature.com · 12/05/2026

Circling back to RNA vaccines go.nature.com/3RzqxHN

041

Nature Biotechnology @natbiotech.nature.com · 11/05/2026

Progress toward a true virtual cell will depend on uniting AI’s pattern-finding power with the causal rigor of mechanistic models go.nature.com/48muYvd rdcu.be/fh599

051

Nature Biotechnology @natbiotech.nature.com · 06/05/2026

HKUST researchers flip the CRISPR script to develop world's first DNA-guided gene editing tool for precise infectious disease diagnosis and advancing antiviral therapies #NBTintheNews hkust.edu.hk/news/hkust-r...

020

Nature Biotechnology @natbiotech.nature.com · 05/05/2026

Advancing care with digital lungs Scientists at UHN develop digital twins of human lungs using Ex Vivo Lung Perfusion data #NBTintheNews www.uhnresearch.ca/news/5-04-20...

000

Nature Biotechnology @natbiotech.nature.com · 29/04/2026

Synthetic biology’s uncertain regulatory future in the wake of Loper Bright Enterprises v. Raimondo go.nature.com/4cE794D

031

Nature Biotechnology @natbiotech.nature.com · 23/04/2026

Establishing a commercial solution for extremely rare genetic diseases go.nature.com/4aHSIvu

010

Nature Biotechnology @natbiotech.nature.com · 22/04/2026

Engineered dual-bacterial sensors turn chemical signals into electricity #NBTintheNews news.rice.edu/news/2026/en...

010

Nature Biotechnology @natbiotech.nature.com · 22/04/2026

Scientists snap kinases in motion to reveal ‘invisible’ states for drug discovery www.nature.com/articles/s41... [🔓read free with login]

093